🇺🇸 FDA
Pipeline program

Phage Therapy

APT.PJI.001

Phase 2 mab terminated

Quick answer

Phage Therapy for Prosthetic Joint Infection is a Phase 2 program (mab) at Adaptive Biotechnologies Corp with 2 ClinicalTrials.gov record(s).

Program details

Company
Adaptive Biotechnologies Corp
Indication
Prosthetic Joint Infection
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials